EJNMMI Research

Article	Citations
18 F-Choline-PET/CT for non-FDG-avid salivary gland cancer: a preliminary report	45
Change in brain amyloid load and cognition in patients with amnestic mild cognitive impairment: a 3-year follow-up study	39
Influence of corticosteroid treatment on CXCR4 expression in DLBCL	33
Imaging tumor and ascites-associated macrophages in a mouse model of metastatic ovarian cancer	29
Biodistribution and dosimetry of the PET radioligand [18F]CHDI-650 in mice for detection of mutant huntingtin aggregates	28
[18F]F-FES PET for diagnosis, staging, and endocrine therapy prediction in ER-positive breast cancer: a systematic review and meta-analysis	28
89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism	27
Combatting the effect of image reconstruction settings on lymphoma [18F]FDG PET metabolic tumor volume assessment using various segmentation methods	25
Adenosine-induced splenic switch-off on [15O]H2O PET perfusion for the assessment of vascular vasodilatation	25
Cardiometabolic disorders affect myocardial [18F]fluorodeoxyglucose uptake– impact on diagnostic PET/CT imaging	23
Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, n	23
18F-FDG PET/CT-based deep learning radiomics predicts 5-years disease-free survival after failure to achieve pathologic complete response to neoadjuvant chemotherapy in breast cancer	22
Hypometabolism and atrophy patterns associated with Niemann-Pick type C	22
Quantification of [99mTc]Tc-HDP bone SPECT/CT: can we improve the body weight based standardized uptake value with a more robust normalization?	22
Association of white matter injury and neuroinflammation in the post-acute phase after ischemic stroke using [18F]FEPPA-PET/MRI	21
Quantitative renal [99mTc]DMSA imaging predicts urinary [99mTc]DMSA excretion in patients with chronic kidney disease	21
Test-retest repeatability of quantitative organ and tissue uptake using 20-minute dynamic multiparametric whole-body [18F]FDG PET/CT in patients with type 2 diabetes	21
Radiation dosimetry and fasting-dependent hepatobiliary clearance of the VAChT-specific PET radioligand 18F-VAT in humans	19
First clinical experience with fractionated intracavitary radioimmunotherapy using [177Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot study	19
Impact of administered amount of peptide on tumor dosimetry at the first cycle of peptide receptor radionuclide therapy (PRRT) in relation to total tumor somatostatin receptor expression	19
The value of radiomics based on 2-[18 F]FDG PET/CT in predicting WHO/ISUP grade of clear cell renal cell carcinoma	18
Toward in vivo proof of binding of 18F-labeled inhibitor [18F]TRACK to peripheral tropomyosin receptor kinases	18
Drug characteristics derived from kinetic modeling: combined 11C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A	17
All that glitters is not gold: high uptake on PSMA PET in non-prostate cancers does not mean that treatment with [177Lu]Lu-PSMA-radioligand will be successful	16
Preliminary mechanistic insights of a brain-penetrant microtubule imaging PET ligand in a tau-knockout mouse model	16

A biorthogonal chemistry approach for high-contrast antibody imaging of lymphoma at early time points	15
Predicting the effect of different folate doses on [68Ga]Ga-PSMA-11 organ and tumor uptake using physiologically based pharmacokinetic modeling	15
PET imaging of GABAA receptors in pancreatic islets by [11C]flumazenil	14
Semi-quantitative indices of 2-[18F]FDG PET/CT in assessing cardiovascular and non-cardiovascular manifestations of IgG4-related disease and treatment response	14
The effects of novel macrocyclic chelates on the targeting properties of the 68Ga-labeled Gastrin releasing peptide receptor antagonist RM2	14
Autoradiographic comparison between [11C]PiB and [18F]AZD4694 in human brain tissue	14
CYP3A4 inhibitors do not influence [68Ga]Ga-DOTA-TATE uptake in liver tissue	14
TCP post-radioembolization and TCP post-EBRT in HCC are similar and can be predicted using the in vitro radiosensitivity	14
Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation	14
Hepatobiliary PET with [68Ga]Ga-BP-IDA – preclinical evaluation and its translational potential for liver function monitoring	14
Reduced splenic uptake of [68Ga]Ga-Pentixafor following first-line chemotherapy is associated with poor prognosis in patients with newly diagnosed multiple myeloma	14
First-in-human use of 11C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor	13
Matched-pair analysis of mCRPC patients receiving 177Lu-labeled PSMA-targeted radioligand therapy in a 4-week versus 6-week treatment interval	13
A dual-tracer approach using [11C]CH and [18F]FDG in HCC clinical decision making	13
cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET/CT volumetric parameters in patients with biochemical recurrence of prostate cancer	12
Effect of the identification group size and image resolution on the diagnostic performance of metabolic Alzheimer’s disease-related pattern	12
Engineering a modular 44Ti/44Sc generator: eluate evaluation in preclinical models and estimation of human radiation dosimetry	12
A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptides	12
Magnetic resonance spectroscopy for enhanced multiparametric MRI characterization of [18F]FET PET-negative gliomas	12
[18F]FDOPA PET/CT is superior to [68Ga]DOTATOC PET/CT in diagnostic imaging of pheochromocytoma	12
Ultrasensitive detection of uveal melanoma using [18F]AlF-NOTA-PRGD2 PET imaging	12
Correction: [18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism	12
MRI ensemble model of plaque and perivascular adipose tissue as PET-equivalent for identifying carotid atherosclerotic inflammation	12
Evaluation of therapeutic effect and prognostic value of 18F-FDG PET/CT in different treatment nodes of DLBCL patients	11
Reorganization of brain connectivity in post-COVID condition: a 18F-FDG PET study	11
Development and validation of 68Ga-PSMA-11 PET/CT-based radiomics model to detect primary prostate cancer	11
Distinguishing lymphoma from benign lymph node diseases in fever of unknown origin using PET/CT radiomics	11
Fc-engineered monoclonal antibodies to reduce off-target liver uptake	11
Molecular imaging in hypertrophic cardiomyopathy: an exploratory study with 2-[18F]FDG and [13N]NH3	11
A study method using early dynamic acquisition of [18F]fluorodopa positron emission tomography for the differential diagnosis between progression and radionecrosis of brain metastases after radiothera	11
Quantification in respiratory-gated PET acquisition: can data-driven methods replace device-based systems?—a comparative and retrospective study	11
Prognostic value of 18F-FDG PET/CT-based radiomics combining dosiomics and dose volume histogram for head and neck cancer	11
68Ga-Pentixafor PET/CT for the assessment of therapeutic outcomes following superselective adrenal arterial embolization in patients with primary aldosteronism	10
The effect of androgen blockade on [68Ga]Ga-PSMA-11 and [18F]FDG PET uptake in patients with recurrent or metastatic salivary duct carcinoma: a prospective imaging study	10
Quantitative terbium-161 SPECT/CT imaging: demonstrating the feasibility of image-based dosimetry and highlighting pitfalls	10
Characterization of in vivo binding kinetics and non-displaceable binding of [18F]SynvesT-1 in the rat brain	10
Deep learning-based radiolabelled compound-protein interaction prediction for NDUFS1-targeting radiopharmaceutical discovery	10
Reduced hematopoietic-inflammatory response and worse outcomes in patients with recurrent myocardial infarction in comparison with primary myocardial infarction	10
Biphasic contrast-enhanced [18F]PSMA-1007 PET/CT imaging to improve the detection of local relapse of prostate cancer	10
Molecular imaging of fibroblast activation in multiple non-ischemic cardiomyopathies	10
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases	10
Imaging renal mitochondrial dysfunction in chronic kidney disease: a repurposed role for [99mTc]Tc-MIBI SPECT/CT	10
Effects of furosemide and tracer selection on urinary activity and peri-bladder artefacts in PSMA PET/CT: a single-centre retrospective study	9
3′-deoxy-3′-18F-fluorothymidine PET imaging of lymphoid tissues in patients with advanced non-small cell lung cancer undergoing anti-programmed cell death-1 therapy	9
Spatial distribution of fractionally administered holmium microspheres in non-tumorous human liver tissue: how livers survive transarterial radioembolisation	9
Dopamine transporter single-photon emission computed tomography-derived radiomics signature for detecting Parkinson’s disease	9
Accuracy of dynamic sentinel lymph node biopsy for inguinal lymph node staging in cN0 penile cancer	9
[18F]FDG PET-MR characterization of aortitis in the IL1rn−/− mouse model of giant-cell arteritis	9
[18F]ROStrace detects oxidative stress in vivo and predicts progression of Alzheimer’s disease pathology in APP/PS1 mice	9
Phantom and clinical evaluation of the effect of a new Bayesian penalized likelihood reconstruction algorithm (HYPER Iterative) on 68Ga-DOTA-NOC PET/CT image quality	9

Exploring the impact of PEGylation on pharmacokinetics: a size-dependent effect of polyethylene glycol on prostate-specific membrane antigen inhibitors	9
Total-body 18F-FDG PET/CT: more choices to promote clinical scanning efficiency	9
Characterisation of a novel [18F]FDG brain PET database and combination with a second database for optimising detection of focal abnormalities, using focal cortical dysplasia as an example	9
68Ga-NOTA-RM26 PET/CT in the evaluation of glioma: a pilot prospective study	9
Imaging bone turnover assessment through volumetric density-adjusted standardized uptake value using quantitative bone SPECT/CT in osteoporosis	9
Tumor sink effect on melanin-ligand [131I]ICF01012 in melanoma and its implications for targeted radionuclide therapy	9
Development of [89Zr]Zr-hCD103.Fab01A and [68Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively assess cancer reactive T cell infiltration: Fab-based CD103 immunoPET	9
Evaluation of the theranostic potential of [64Cu]CuCl2 in glioblastoma spheroids	8
Chemotherapy alters radiosensitivity and GRPR expression of prostate and breast cancer cells	8
Impact of brain segmentation methods on regional metabolism quantification in 18F-FDG PET/MR analysis	8
Metabolic phenotyping of hand automatisms in mesial temporal lobe epilepsy	8
Effect of radiation therapy on lymph node fluorescence in head and neck squamous cell carcinoma after intravenous injection of indocyanine green: a prospective evaluation	8
Prostate-specific membrane antigen (PSMA) expression in primary and metastatic renal cell cancer (UroCCR-65 study)	8
Predictive value of 68[Ga]Ga-DOTA-TATE PET/CT volumetric parameters in assessing treatment response to long-acting somatostatin analogues in patients with well-differentiated neuroendocrine tumours	8
Light up heart-type fatty acid binding protein (FABP3) with a novel fluorine-18 labelled selective FABP3 ligand	8
Myocardial glucose suppression may interfere with the detection of inflammatory cells with FDG-PET as suggested in a canine model of myocardial infarction	8
Effect of cerebral sinus venous thrombosis and its location on cerebral blood flow: a [15O]water PET study in acute stroke patients compared to healthy volunteers	8
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer	8
Preclinical evaluation of Affibody molecule for PET imaging of human pancreatic islets derived from stem cells	8
Blood-based transcriptomic biomarkers for response to [177Lu]Lu-DOTA-TATE therapy in neuroendocrine tumors	8
Predicting survival, neurotoxicity and response in B-cell lymphoma patients treated with CAR-T therapy using an imaging features-based model	8
A histogram of [18F]BBPA PET imaging differentiates non-neoplastic lesions from malignant brain tumors	8
Feasibility of a drop-in γ-probe for radioguided sentinel lymph detection in early-stage cervical cancer	8
Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in patients and clinically realistic simulations	8
[195mPt]Cisplatin for lung cancer imaging: a pilot study	8
Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers	7
A feasibility study of [18F] FDG PET/CT radiomics in predicting high-risk cytogenetic abnormalities in multiple myeloma	7
External validation: a simulation study to compare cross-validation versus holdout or external testing to assess the performance of clinical prediction models using PET data from DLBCL patients	7
18F-ASEM PET/MRI targeting alpha7-nicotinic acetylcholine receptor can reveal skeletal muscle denervation	7
The assessment of left ventricular volume and function in gated small animal 18F-FDG PET/CT imaging: a comparative study of three commercially available software tools	7
AI may help to predict thyroid nodule malignancy based on radiomics features from [18F]FDG PET/CT	7
Myocardial perfusion and oxidative metabolism in healthy subjects: sex-specific insights from vasodilatory stress 11C-acetate PET	7
Target occupancy study and whole-body dosimetry with a MAGL PET ligand [11C]PF-06809247 in non-human primates	7
Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated 18F-fluorination of boroxines, in vitro and initial in vivo evaluation	7
The effect of butylscopolamine on [18F]FDG uptake in the gastrointestinal tract is negligible and regionally variable	7
The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy	7
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): methodological application in [18F]-FDOPA PET imaging	7
Biological efficacy of simulated radiolabeled Lipiodol® ultra-fluid and microspheres for various beta emitters: study based on VX2 tumors	7
The intra- and interobserver variability of PSMA-expression scores in patients with primary prostate cancer	7
Clinical feasibility and impact of data-driven respiratory motion compensation studied in 200 whole-body 18F-FDG PET/CT scans	7
Clinical significance of diffuse [18F] AlF-NOTA-FAPI-04 uptake in the thyroid on PET/CT imaging	6
Kinetics of the amino acid uptake tracer O-(2-[18F]fluoroethyl)-L-tyrosine (FET) in human brain	6
Utility of quantitative standardized uptake value from pre-operative bone SPECT/CT for predicting post-surgical MRONJ healing response	6
Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging	6
CXCR4-targeted PET imaging in rheumatoid arthritis: a novel approach for monitoring disease activity and therapeutic response	6
Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study	6
Brown adipose tissue machine learning nnU-Net V2 network using TriDFusion (3DF)	6
Comparative benefits of Ki and SUV images in lesion detection during PET/CT imaging	6
Peptide-based PET imaging agent of tumor TIGIT expression	6
Is CXCR4-targeted 68Ga-pentixafor PET/CT a reliable AVS-free modality for surgical decision-making and prognostic prediction in primary aldosteronism with bilateral adrenal lesions?	6
Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphoma	6
The remodeling of metabolic brain pattern in patients with extracranial diffuse large B-cell lymphoma	6
Neuropathological correlations of 18F-florzolotau PET in a case with Pick’s disease	6
Radiation protection considerations with [89Zr]Zr-girentuximab PET and surgery	6
Model selection for dynamic PET compartmental modelling of 18F-FDG uptake using a long axial field-of-view PET scanner with delay and motion correction	6
Predictive value of 99mTc-MAA-based dosimetry in personalized 90Y-SIRT planning for liver malignancies	6
Non-invasive quantification of 18F-florbetaben with total-body EXPLORER PET	6
Evaluation of [11C]UCB-A positron emission tomography in human brains	6
Pulmonary uptake value (PUV): a new quantification method for lung PET/CT imaging	5
Impact of non-regional lymph node metastases accurately revealed on 18F-PSMA-1007 PET/CT in the clinical management of metastatic hormone-sensitive prostate cancer	5
In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [177Lu]Lu-PP-F11N in humans: the lumed phase 0b study	5
Improving multi-pinhole CZT myocardial perfusion imaging specificity without changing sensibility by using adapted filter parameters	5
Differentiation and correlation of regional uptake heterogeneity with cardiac dysfunction in biopsy-proven transthyretin amyloid cardiomyopathy using quantitative single-photon emission computed tomog	5
Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients	5
Diagnostic models for fever of unknown origin based on 18F-FDG PET/CT: a prospective study in China	5
[68 Ga]Ga-FAPI-04 PET/CT may be a predictor for early treatment response in rheumatoid arthritis	5
Test-retest properties of [11C]PXT012253 as a positron emission tomography (PET) radiotracer in healthy human brain: PET imaging of mGlu4	5
Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough	5
Clinical utility of 18F-FDG PET/CT imaging in patients with pulmonary artery sarcoma	5
Preoperative assessment and prognostic prediction of gastric cancer patients with peritoneal metastasis using 18F-FDG PET/CT before conversion surgery	5
PSMA-expressing, fluciclovine-negative vertebral hemangioma	5
Evaluation of damage discrimination in dopaminergic neurons using dopamine transporter PET tracer [18F]FECNT-d4	5
Deep learning for Parkinson’s disease classification using multimodal and multi-sequences PET/MR images	5
18F-FDG-PET/CT-based deep learning model for fully automated prediction of pathological grading for pancreatic ductal adenocarcinoma before surgery	5
[18F]Fluoride uptake in various bone types and soft tissues in rat	5
The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis	5
A preclinical study on the influence of linkers in [68Ga]Ga-NOTA-X-RM26 radiotracers for PET imaging of GRPR expression	5
Simultaneous 18F-FDG PET/MR metabolic and structural changes in visual snow syndrome and diagnostic use	5
Diagnostic accuracy of cerebral [18F]FDG PET in atypical parkinsonism	5
Lymphoscintigraphy findings in patients with chylothorax: influence of biochemical parameters	5

Heart ketone metabolism under acute ketone supplementation in ZDF rats, a type 2 diabetes heart failure model	5
Evaluation of a simplified radiolabeling method for a PARP inhibitor in an animal model of breast cancer	5
Effects of isoflurane anaesthesia depth and duration on renal function measured with [99mTc]Tc-mercaptoacetyltriglycine SPECT in mice	4
Normal values for 18F-FDG uptake in organs and tissues measured by dynamic whole body multiparametric FDG PET in 126 patients	4
A heterodimeric radioligand labeled with gallium-68 targeting fibroblast activation protein	4
Correction: Diagnostic and evaluative efficiency of 68Ga-FAPI-04 in skeletal muscle injury	4
The efficacy of short acquisition time using 18F-FDG total-body PET/CT for the identification of pediatric epileptic foci	4
Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA	4
The impact of patient hydration and forced diuresis on [18F]PSMA-1007 urinary bladder uptake in PET/CT imaging	4
Relaxed fibronectin: a potential novel target for imaging endometriotic lesions	4
Diagnostic and evaluative efficiency of 68Ga-FAPI-04 in skeletal muscle injury	4
Comparison of tracer kinetic models for 68Ga-PSMA-11 PET in intermediate-risk primary prostate cancer patients	4
Baseline 18F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma	4
Elimination of artifacts caused by residual radiopharmaceutical activity in injection site in myocardial perfusion imaging on Discovery NM 530c semiconductor gamma camera	4
Non-invasive arterial input function estimation using an MRA atlas and machine learning	4
Assessing the impact of different penalty factors of the Bayesian reconstruction algorithm Q.Clear on in vivo low count kinetic analysis of [11C]PHNO brain PET-MR studies	4
Radiofluorination of a highly potent ATM inhibitor as a potential PET imaging agent	4
In reply to Cheng et al. (DOI: 10.1186/s13550-023-00965-8)	4
Visualizing GABA transporters in vivo: an overview of reported radioligands and future directions	4
Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy	4
A physiologically based pharmacokinetic model for [68Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients	4
Early diagnosis and staging of paraquat-induced pulmonary fibrosis using [18F]F-FAPI-42 PET/CT imaging	3
Influence of fasting prior to 18F-rhPSMA-7.3 (Flotufolastat F-18) PET/CT on biodistribution and tumor uptake	3
The image quality and feasibility of solitary delayed [68 Ga]Ga-PSMA-11 PET/CT using long field-of-view scanning in patients with prostate cancer	3
Prospective phase II trial of [68Ga]Ga-NOTA-AE105 uPAR-PET/MRI in patients with primary gliomas: Prognostic value and Implications for uPAR-targeted Radionuclide Therapy	3
P2X 7-receptor binding in new-onset and secondary progressive MS – a [11C]SMW139 PET study	3
Preclinical evaluation and first-in-human study of [18F]AlF-FAP-NUR for PET imaging cancer-associated fibroblasts	3
Use of relative Patlak plot Ki′ images as an alternative to standard Patlak plot Ki images in clinical practice	3
PSMA imaging as a non-invasive tool to monitor inducible gene expression in vivo	3
Preclinical biodistribution and dosimetry and human biodistribution comparing 18F-rhPSMA-7 and single isomer 18F-rhPSMA-7.3	3
First experiences with 177Lu-PSMA-617 therapy for recurrent or metastatic salivary gland cancer	3
Measurement of specific and nonspecific tissue uptake of antibodies in tumor by SPECT imaging and nonlinear compartmental modeling	3
Heparin does not improve myocardial glucose metabolism suppression in [18 F]FDG PET/CT in patients with low β-hydroxybutyrate level	3
Evaluation of gastrin-releasing peptide receptor, prostate-specific membrane antigen, and neurotensin receptor 1 as potential biomarkers for accurate prostate cancer stratified diagnosis	3
New improved radiometabolite analysis method for [18F]FTHA from human plasma: a test-retest study with postprandial and fasting state	3
Targeted imaging of very late antigen-4 for noninvasive assessment of lung inflammation-fibrosis axis	3
Quantitative evaluation of thyroid bed accumulation in I-131 radiotherapy: a comparison of laryngeal edema and non-edematous cases	3
Altered glucose metabolism in default mode network and prefrontal circuit in patients with Kallmann syndrome	3
Discrimination of benign, atypical, and malignant peripheral nerve sheath tumours in neurofibromatosis type 1 – intraindividual comparison of positron emission computed tomography and diffusion-weight	3
Multinomial logistic regression algorithm for the classification of patients with parkinsonisms	3
Effect of β3-adrenergic receptor agonists on [18F] fluorodeoxyglucose uptake in brown adipose tissues in positron emission tomography images of elderly patients	3
Biomarkers of bone metabolism in [223Ra] RaCl2 therapy - association with extent of disease and prediction of overall survival	3
The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology	3
Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials	3
Tolerability of PSMA radioligand therapy in metastatic prostate cancer patients with baseline mild to moderate leukopenia	3
A convolutional neural network for total tumor segmentation in [64Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms	3
In vivo vesicular acetylcholine transporter density in human peripheral organs: an [18F]FEOBV PET/CT study	3
Physiological provocation compared to acetazolamide in the assessment of cerebral hemodynamics: a case report	3
ImmunoPET provides a novel way to visualize the CD103+ tissue-resident memory T cell to predict the response of immune checkpoint inhibitors	3
[68Ga] labelled Exendin for radioguided surgery of intrapancreatic insulin producing lesions in patients with congenital hyperinsulinism	3
In silico analysis of radiation-induced double-strand breaks by internal ex vivo irradiation of lymphocytes for 45 alpha- and beta/gamma-emitting radionuclides	3
Effects of novel androgen receptor signaling inhibitors on PSMA PET signal intensity in patients with castrate-resistant prostate cancer: a prospective exploratory serial imaging study	3
Larger 18F-fluoroboronotyrosine (FBY) active volume beyond MRI contrast enhancement in diffuse gliomas than in circumscribed brain tumors	3
Comparison of [18F]-FDOPA PET and [123I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome	2
Brain 18 F-FDG PET reveals cortico-subcortical hypermetabolic dysfunction in juvenile neuropsychiatric systemic lupus erythematosus	2
CXCR4 peptide-based fluorescence endoscopy in a mouse model of Barrett’s esophagus	2
Radiomics predictive modeling from dual-time-point FDG PET Ki parametric maps: application to chemotherapy response in lymphoma	2
Detection of the sentinel lymph node with hybrid tracer (ICG-[99mTc]Tc-albumin nanocolloid) in intermediate- and high-risk endometrial cancer: a feasibility study	2
Correction: The association of DAT gene methylation with striatal DAT availability in healthy subjects	2
Radiosynthesis automation, non-human primate biodistribution and dosimetry of K+ channel tracer [11C]3MeO4AP	2
Cerebellum/liver index on baseline 18F-FDG PET/CT to improve prognostication in post-transplant lymphoproliferative disorders: a multicenter retrospective study	2
The potential application of MR-derived ADCmin values from 68Ga-DOTATATE and 18F-FDG dual tracer PET/MR as replacements for FDG PET in assessment of grade and stage of pancreatic neuroendocrine tumors	2
Vessel-by-vessel analysis of lower extremity 18F-NaF PET/CT imaging quantifies diabetes- and chronic kidney disease-induced active microcalcification in patients with peripheral arterial disease	2
Assessment of resting myocardial blood flow in regions of known transmural scar to confirm accuracy and precision of 3D cardiac positron emission tomography	2
Radioimmunotherapy study of 131I-labeled Atezolizumab in preclinical models of colorectal cancer	2
Machine learning for prognostic prediction in coronary artery disease with SPECT data: a systematic review and meta-analysis	2
Staging lung cancer: total-body PET/CT or whole-body PET/CT?	2
Automated extraction of the arterial input function from brain images for parametric PET studies	2
Influence of oral protein intake on [18F]FET uptake in brain tumours	2
CMR validation of left ventricular volumes and ejection fraction measured by the IQ-SPECT system in patients with small heart size	2
Mid-treatment changes in intra-tumoural metabolic heterogeneity correlate to outcomes in oropharyngeal squamous cell carcinoma patients	2
Initial evaluation of [18F]-FACBC for PET imaging of multiple myeloma	2
Development of a minimally invasive simultaneous estimation method for quantifying translocator protein binding with [18F]FEPPA positron emission tomography	2
The impact of introducing deep learning based [18F]FDG PET denoising on EORTC and PERCIST therapeutic response assessments in digital PET/CT	2
Investigation of atovaquone-induced spatial changes in tumour hypoxia assessed by hypoxia PET/CT in non-small cell lung cancer patients	2
Correction: Quantification of [99mTc]Tc-HDP bone SPECT/CT: can we improve the body weight based standardized uptake value with a more robust normalization?	2
Amyloid PET quantification using low-dose CT-guided anatomic standardization	2
Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell carcinoma	2
Preclinical evaluation of [18F]FP-CIT, the radiotracer targeting dopamine transporter for diagnosing Parkinson’s disease: pharmacokinetic and efficacy analysis	2
Cardiac sympathetic activity and lethal arrhythmic events: insight into bell-shaped relationship between 123I-meta-iodobenzylguanidine activity and event rates	2
In vitro and ex vivo evaluation of preclinical models for FAP-targeted theranostics: differences and relevance for radiotracer evaluation	2
Clinical value of Tc-99m MDP SPECT/CT bone imaging for early diagnosis of Relapsing Polychondritis: a report of 5 cases	2
An update on the use of image-derived input functions for human PET studies: new hopes or old illusions?	2
SPECT/CT in addition to subtraction parathyroid scintigraphy in hyperparathyroidism: diagnostic performance in a cohort of predominantly end-stage renal disease patients	2
3D-printed dual holder system for simultaneous rat PET scanning: design and influence on quantification	2
Unravelling physical and radiobiological effects of proton boron fusion reaction with anionic metallacarboranes ([o-COSAN]-) in breast cancer cells	2
Software compatibility analysis for quantitative measures of [18F]flutemetamol amyloid PET burden in mild cognitive impairment	2
Increased lesion detectability in patients with locally advanced breast cancer—A pilot study using dynamic whole-body [18F]FDG PET/CT	2
Primary mesenchymal tumors of the prostate:18F FDG PET/CT findings	2
Post-treatment three-dimensional voxel-based dosimetry after Yttrium-90 resin microsphere radioembolization in HCC	2
Establishing cutoff values for visual amyloid positivity in [18F]flutemetamol PET	2
The predictive value of [18F]FDG PET/CT radiomics combined with clinical features for EGFR mutation status in different clinical staging of lung adenocarcinoma	2
Pilot study of humanized glypican-3-targeted zirconium-89 immuno-positron emission tomography for hepatocellular carcinoma	2